MENU
ONC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BeOne Medicines (ONC) Ownership - Who owns BeOne Medicines?

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
c/o BeOne Medicines I GmbH
Phone
+41 616851900
Employees
12000
Web
https://www.beonemedicines.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
41.82B
P/E Ratio
64.55
Total Cash
5.1B
Projected Growth
0.76
Total Debt
1.14B
Revenue
6.13B
Risk (Beta)
0.51
Dividend Yield
N/A
Total Cash/Share
45.07
Total Debt/Equity
N/A
Revenue/Share
53.10 USD as % of share price
View a ticker or compare two or three
ONC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Industry
Biotechnology
Address
c/o BeOne Medicines I GmbH
Phone
+41 616851900
Employees
12000
Web
https://www.beonemedicines.com
Who owns BeOne Medicines? ONC symbol Ownership - Tickeron.com